Blue laser magnifying endoscopy in the diagnosis of chronic gastritis

Zhu,Ying; Wang,Fang; Zhou,Yan; Xia,Gui‑Li; Dong,Ling; He,Wen‑Hua; Xiao,Bing

doi:10.3892/etm.2019.7811

Blue laser magnifying endoscopy in the diagnosis of chronic gastritis

Authors:
- Ying Zhu
- Fang Wang
- Yan Zhou
- Gui‑Li Xia
- Ling Dong
- Wen‑Hua He
- Bing Xiao
View Affiliations

Affiliations: Department of Gastroenterology, Shenzhen Hospital of Southern Medical University, Shenzhen, Guangdong 518100, P.R. China, Department of Information Management Section, Bethune International Peace Hospital, Shijiazhuang, Hebei 050000, P.R. China, Department of Gastroenterology, Nanfang Hospital, Southern Medical University, Guangzhou, Guangdong 510515, P.R. China
Published online on: July 25, 2019 https://doi.org/10.3892/etm.2019.7811
Pages: 1993-2000
Copyright: © Zhu et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

The current study aimed to evaluate the clinical value of using blue laser imaging combined with magnifying endoscopy in the diagnosis of chronic gastritis (CG). The groups used were as follows: The white light group (WLI, control group), linked color imaging group (LCI, observation group 1), blue laser imaging (BLI)‑bright (brt) group (BLI‑brt; observation group 2), BLI + magnified imaging (ME) group (observation group 3). WLI mode initially allowed the observation of mucosal suspicious lesions on the gastric mucosa. These lesions were photographed and the mode was changed to LCI, BLI‑brt and BLI + ME. Different observational patterns were compared between modes to diagnose various grades of chronic gastritis. No significant differences were observed in the baseline information of enrolled patients. The LCI mode diagnosis rate was higher for Helicobacter pylori (HP) infection than in any other mode. LCI exhibited a high diagnostic rate for HP, BLI‑brt exhibited a high diagnostic rate for atrophy and BLI/BLI + ME exhibited a high diagnostic rate for intestinal metaplasia and intraepithelial neoplasia. All modes exhibited higher diagnostic rates compared with the WLI mode. The pathological HP diagnosis rate (consistency) of HP infection was the greatest in the LCI group (endoscopic findings and pathological consistency). The BLI‑BRT mode exhibited the highest pathological diagnosis rate for atrophic gastritis and the BLI/BLI + ME mode exhibited the highest diagnostic rate for intestinal metaplasia and low‑grade intraepithelial neoplasia.

View Figures

View References

1	Çolakoğlu EÇ, Börkü K, Haydardedeoğlu AE, Alihosseini H, Şenel OO, Yumuşak N, Özen D, Baş B and Uğurlu L: Correlation between endoscopic and histopathological findings in dogs with chronic gastritis. J Vet Res. 61:351–355. 2017. View Article : Google Scholar : PubMed/NCBI
2	Liu Y, Gong H, Liu J and Zhang H: Acupoint selection pattern of chronic atrophic gastritis based on data mining methods of latent structure model and frequency item set. Zhongguo Zhen Jiu (Chinese). 38:667–671. 2018.
3	Cherdantseva LA, Potapova OV, Sharkova TV, Belyaeva YY and Shkurupiy VA: Association of Helicobacter pylori and iNOS production by macrophages and lymphocytes in the gastric mucosa in chronic gastritis. J Immunol Res. 2014:7625142014. View Article : Google Scholar : PubMed/NCBI
4	Sonnenberg A and Genta RM: Prevalence of benign gastric polyps in a large pathology database. Dig Liver Dis. 47:164–169. 2015. View Article : Google Scholar : PubMed/NCBI
5	Jiang JX, Liu Q, Zhao B, Zhang HH, Sang HM, Djaleel SM, Zhang GX and Xu SF: Risk factors for intestinal metaplasia in a southeastern Chinese population: An analysis of 28,745 cases. J Cancer Res Clin Oncol. 143:409–418. 2017. View Article : Google Scholar : PubMed/NCBI
6	Tsimmerman YS and Zakharova YA: Kyoto consensus-The new etiological classification of chronic gastritis and its discussion. Klin Med (Mosk) (Russian). 95:181–188. 2017.
7	Tsimmerman YS and Zakharova YA: Topical problems of chronic gastritis. Klin Med (Mosk) (Russian). 95:8–14. 2017.
8	Yoon H and Kim N: Diagnosis and management of high risk group for gastric cancer. Gut Liver. 9:5–17. 2015. View Article : Google Scholar : PubMed/NCBI
9	Pasechnikov V, Chukov S, Fedorov E, Kikuste 1 and Leja M: Gastric cancer: Prevention, screening and early diagnosis. World J Gastroenterol. 20:13842–13862. 2014. View Article : Google Scholar : PubMed/NCBI
10	Rudnicka K, Backert S and Chmiela M: Genetic polymorphisms in inflammatory and other regulators in gastric cancer: Risks and clinical consequences. Curr Top Microbiol Immunol. 421:53–76. 2019.PubMed/NCBI
11	Strong VE, Wu AW, Selby LV, Gonen M, Hsu M, Song KY, Park CH, Coit DG, Ji JF and Brennan MF: Differences in gastric cancer survival between the U.S and China. J Surg Oncol. 112:31–37. 2015. View Article : Google Scholar : PubMed/NCBI
12	Karimi P, Islami F, Anandasabapathy S, Freedman ND and Kamangar F: Gastric cancer: Descriptive epidemiology, risk factors, screening, and prevention. Cancer Epidemiol Biomarkers Prev. 23:700–713. 2014. View Article : Google Scholar : PubMed/NCBI
13	Yoshida N, Dohi O, Inoue K, Yasuda R, Murakami T, Hirose R, Inoue K, Naito Y, Inada Y, Ogiso K, et al: Blue laser imaging, blue light imaging, and linked color imaging for the detection and characterization of colorectal tumors. Gut Liver. 13:140–148. 2019. View Article : Google Scholar : PubMed/NCBI
14	Nakashima H, Kawahira H, Kawachi H and Sakaki N: Artificial intelligence diagnosis of Helicobacter pylori infection using blue laser imaging-bright and linked color imaging: A single-center prospective study. Ann Gastroenterol. 31:462–468. 2018.PubMed/NCBI
15	Togashi K, Nemoto D, Utano K, Isohata N, Kumamoto K, Endo S and Lefor AK: Blue laser imaging endoscopy system for the early detection and characterization of colorectal lesions: A guide for the endoscopist. Therap Adv Gastroenterol. 9:50–56. 2016. View Article : Google Scholar : PubMed/NCBI
16	Horiguchi N, Tahara T, Kawamura T, Okubo M, Tahara S, Nagasaka M, Nakagawa Y, Shibata T and Ohmiya N: A comparative study of white light endoscopy, chromoendoscopy and magnifying endoscopy with narrow band imaging in the diagnosis of early gastric cancer after Helicobacter pylori eradication. J Gastrointestin Liver Dis. 26:357–362. 2017.PubMed/NCBI
17	Osawa H and Yamamoto H: Present and future status of flexible spectral imaging color enhancement and blue laser imaging technology. Dig Endosc Suppl. 1:105–115. 2014. View Article : Google Scholar
18	Zhou F, Wu L, Huang M, Jin Q, Qin Y and Chen J: The accuracy of magnifying narrow band imaging (ME-NBI) in distinguishing between cancerous and noncancerous gastric lesions: A meta-analysis. Medicine (Baltimore). 97:e97802018. View Article : Google Scholar : PubMed/NCBI
19	Nagahama T, Yao K, Uedo N, Doyama H, Ueo T, Uchita K, Ishikawa H, Kanesaka T, Takeda Y, Wada K, et al: Delineation of the extent of early gastric cancer by magnifying narrow-band imaging and chromoendoscopy: A multicenter randomized controlled trial. Endoscopy. 50:566–576. 2018. View Article : Google Scholar : PubMed/NCBI
20	Diao W, Huang X, Shen L and Zeng Z: Diagnostic ability of blue laser imaging combined with magnifying endoscopy for early esophageal cancer. Dig Liver Dis. 50:1035–1040. 2018. View Article : Google Scholar : PubMed/NCBI
21	Cao HL, Dong WX, Xu MQ, Zhang YJ, Wang SN, Piao MY, Cao XC and Wang BM: Clinical features of upper gastrointestinal serrated lesions: An endoscopy database analysis of 98746 patients. World J Gastroenterol. 22:10038–10044. 2016. View Article : Google Scholar : PubMed/NCBI
22	Moehler M, Voigt J, Kastor M, Heil M, Sengespeick C, Biesterfeld S, Dippold W, Kanzler S and Galle PR: Endoscopic ultrasonography-guided fine-needle aspiration (EUS-FNA) as primary diagnostic tool for unclear lesions in the upper gastrointestinal tract. Dtsch Med Wochenschr (German). 136:303–308. 2011. View Article : Google Scholar
23	Society of Digestive Diseases, Chinese Medical Association, Fang Jingyuan, Liu Wenzhong, et al: China Consensus on Chronic Gastritis (Shanghai, 2012). Chinese Journal of Digestion. 33:5–16. 2013.
24	Tian G, Wu C, Li J, Liang B, Zhang F, Fan X, Li Z, Wang Y, Li Z, Liu D, et al: Network pharmacology based investigation into the effect and mechanism of Modified Sijunzi Decoction against the subtypes of chronic atrophic gastritis. Pharmacol Res. 144:158–166. 2019. View Article : Google Scholar : PubMed/NCBI
25	Negovan A, Iancu M, Moldovan V, Sàrkàny K, Bataga S, Mocan S, Țilea I and Banescu C: The contribution of clinical and pathological predisposing factors to severe gastro-duodenal lesions in patients with long-term low-dose aspirin and proton pump inhibitor therapy. Eur J Intern Med. 44:62–66. 2017. View Article : Google Scholar : PubMed/NCBI
26	Fukuda H, Miura Y, Hayashi Y, Takezawa T, Ino Y, Okada M, Osawa H, Lefor AK and Yamamoto H: Linked color imaging technology facilitates early detection of flat gastric cancers. Clin J Gastroenterol. 8:385–389. 2015. View Article : Google Scholar : PubMed/NCBI
27	Guo XY, Dong L, Qin B, Jiang J and Shi AM: Decreased expression of gastrokine 1 in gastric mucosa of gastric cancer patients. World J Gastroenterol. 20:16702–16706. 2014. View Article : Google Scholar : PubMed/NCBI
28	Watari J, Chen N, Amenta PS, Fukui H, Oshima T, Tomita T, Miwa H, Lim KJ and Das KM: Helicobacter pylori associated chronic gastritis, clinical syndromes, precancerous lesions, and pathogenesis of gastric cancer development. World J Gastroenterol. 20:5461–5473. 2014. View Article : Google Scholar : PubMed/NCBI
29	Sipponen P and Maaroos HI: Chronic gastritis. Scand J Gastroenterol. 50:657–667. 2015. View Article : Google Scholar : PubMed/NCBI
30	Kosztyła-Hojna B, Berger G and Zdrojkowski M: Phonosurgical methods of treatment in unilateral vocal folds paralysis. Pol Merkur Lekarski (Polish). 42:173–177. 2017.